Monogram Technologies (Nasdaq:MGRM) announced today that it received FDA 510(k) clearance for its mBôs total knee ...
Roth MKM raised the firm’s price target on Monogram Orthopaedics (MGRM) to $5.40 from $4 and keeps a Buy rating on the shares. The company’s ...
Market the Monogram mBôs TKA System, Subject to the Requirements of the Federal Food, Drug, and Cosmetic Act (the Act).The Company is Preparing for Commercialization and Evaluating Strategies ...
Market the Monogram mBôs™ TKA System, Subject to the Requirements of the Federal Food, Drug, and Cosmetic Act (the Act). The ...